COVID-19–related hospitalizations are up 17% week over week; an estimated 5 to 14 million Americans could lose their Medicaid coverage this year or next year; the CDC is investigating unexplained cases of severe hepatitis in children.
After weeks of rising infection rates, ABC News is reporting that hospitalizations for COVID-19 are up 17% compared with last week, with approximately 2400 infected Americans being admitted each day. Although hospitalizations remain significantly lower than those seen in prior COVID-19 surges, cases of infection have risen 52% in the last 2 weeks and continue to rise; 45 states and territories have seen increases of 10% or more in their daily infection rates. However, average daily COVID-19–related deaths remains low at 340 per day, which is substantially below the 2600 deaths per day reported during the Omicron peak in February.
USA Today is reporting that an estimated 5 to 14 million Americans who gained Medicaid health insurance during the pandemic could lose that coverage this year or next year when federal subsidies end. Over the past 3 fiscal years, the federal government has given states more than $100 billion in Medicaid funds and fiscal relief on the condition they would not remove beneficiaries until the public health emergency ends—and that is set for July 15. When the public health emergency ends, state Medicaid agencies will have 12 months to check the eligibility of each person to determine those who no longer qualify.
The CDC announced during a media briefing on May 6 that it is investigating the 109 cases of severe hepatitis reported in children, 5 of whom have died. As reported by USA Today, the cause of the outbreak, which has spread to 25 states and territories, as well as several other countries, remains unknown. Research from British health officials has suggested that adenovirus may be a potential cause of the unexplained cases of pediatric hepatitis. Approximately 90% of infected children have required hospitalization, with 14% needing liver transplants as a result of severe liver failure.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Traditional Medicare Supplemental Insurance and the Rise of Medicare Advantage
May 7th 2024Rising Medicare Advantage enrollment occurred alongside declines in enrollment in traditional Medicare with employer-sponsored supplemental coverage and traditional Medicare without supplemental coverage.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Senate Finance Committee has introduced bipartisan legislation that proposes using Medicaid and Medicare programs to help prevent and reduce generic drug shortages; US indicators for COVID-19, flu, and respiratory syncytial virus (RSV) declined further last week; findings from a recent study reveal growing disparities in child death rates across racial and ethnic groups.
Read More